Personalized immunotherapies using onconatigen/neoantigen-reactive TCR-engineered T cells

被引：0
|
作者：
Matsuda, Tatsuo [1 ]
Kato, Taigo [1 ]
Ikeda, Yuji [1 ]
Leisegang, Matthias [2 ]
Hikichi, Tetsuro [3 ]
Harada, Makiko [1 ]
Zewde, Makda [1 ]
Park, Jae-Hyun [1 ]
Kiyotani, Kazuma [1 ]
Nakamura, Yusuke [1 ]
机构：
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Charite, Inst Immunol, Campus Buch, Berlin, Germany
[3] OncoTherapy Sci Inc, Kawasaki, Kanagawa, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Personalized immunotherapy; neoantigen;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3002
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [21] Affinity-Enhanced TCR-Engineered T Cells Induce Antimyeloma Responses
    不详
    CANCER DISCOVERY, 2015, 5 (09) : 901 - 901
  • [22] GMP MANUFACTURING OF TCR-ENGINEERED T CELLS IN 5-6 DAYS
    Kalra, M.
    Coughlin, Z.
    Alpert, A.
    Alten, L.
    Bunk, S.
    Wagner, C.
    Fritsche, J.
    Schoor, O.
    Maurer, D.
    Weinschenk, T.
    Sieger, K.
    Mohamed, A.
    Walter, S.
    HUMAN GENE THERAPY, 2019, 30 (12) : A22 - A22
  • [23] Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
    Lowery, Frank J.
    Krishna, Sri
    Yossef, Rami
    Parikh, Neilesh B.
    Chatani, Praveen D.
    Zacharakis, Nikolaos
    Parkhurst, Maria R.
    Levin, Noam
    Sindiri, Sivasish
    Sachs, Abraham
    Hitscherich, Kyle J.
    Yu, Zhiya
    Vale, Nolan R.
    Lu, Yong-Chen
    Zheng, Zhili
    Jia, Li
    Gartner, Jared J.
    Hill, Victoria K.
    Copeland, Amy R.
    Nah, Shirley K.
    Masi, Robert, V
    Gasmi, Billel
    Kivitz, Scott
    Paria, Biman C.
    Florentin, Maria
    Kim, Sanghyun P.
    Hanada, Ken-ichi
    Li, Yong F.
    Ngo, Lien T.
    Ray, Satyajit
    Shindorf, Mackenzie L.
    Levi, Shoshana T.
    Shepherd, Ryan
    Toy, Chris
    Parikh, Anup Y.
    Prickett, Todd D.
    Kelly, Michael C.
    Beyer, Rachel
    Goff, Stephanie L.
    Yang, James C.
    Robbins, Paul F.
    Rosenberg, Steven A.
    SCIENCE, 2022, 375 (6583) : 877 - +
  • [24] A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
    Hanada, Ken-ichi
    Zhao, Chihao
    Gil-Hoyos, Raul
    Gartner, Jared J.
    Chow-Parmer, Christopher
    Lowery, Frank J.
    Krishna, Sri
    Prickett, Todd D.
    Kivitz, Scott
    Parkhurst, Maria R.
    Wong, Nathan
    Rae, Zachary
    Kelly, Michael C.
    Goff, Stephanie L.
    Robbins, Paul F.
    Rosenberg, Steven A.
    Yang, James C.
    CANCER CELL, 2022, 40 (05) : 479 - +
  • [25] Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
    Shafer, Paul
    Kelly, Lauren M.
    Hoyos, Valentina
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
    Chhabra, Arvind
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 121 - 129
  • [27] Autophagic flux restoration of senescent T cells improves antitumor activity of TCR-engineered T cells
    Zhang, Chaoting
    Sun, Yizhe
    Li, Shance
    Shen, Luyan
    Teng, Xia
    Xiao, Yefei
    Zhou, Ping
    Lu, Zheming
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (09)
  • [28] THE ACHILLES VELOS™ PROCESS 2 BOOSTS THE DOSE OF HIGHLY FUNCTIONAL CLONAL NEOANTIGEN-REACTIVE T CELLS FOR PRECISION PERSONALIZED CELL THERAPIES
    Kotsiou, Eleni
    Robinson, Joe
    Rogers, Amber
    Melandri, Daisy
    Baker, Amy
    Aragon, Anabel Ramirez
    Nawaz, Sidra
    Epstein, Michael
    Patel, Shreenal
    Mootien, Jennine
    Craig, Andrew
    Kaur-Lally, Satwinder
    Patel, Hinal
    Schmitt, Andreas
    Islam, Farah
    Jamal-Hanjani, Mariam
    Lawrence, David
    Foster, Martin
    Turajlic, Samra
    Quezada, Sergio
    Newton, Katy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A205 - A205
  • [29] TCR-engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs
    Reuss, Simone
    Sebestyen, Zsolt
    Heinz, Niels
    Loew, Rainer
    Baum, Christopher
    Debets, Reno
    Uckert, Wolfgang
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 265 - 274
  • [30] Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T Cells
    San Miguel, Jesus F.
    Paiva, Bruno
    Lasarte, Juan-Jose
    CANCER CELL, 2015, 28 (03) : 281 - 283
12345